Pregnancy-Related Risk Factors and Glucose Intolerance in Women during Midlife
中年女性妊娠相关危险因素和葡萄糖不耐受
基本信息
- 批准号:8943543
- 负责人:
- 金额:$ 68.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-27 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAncillary StudyAreaBehaviorBirthBirth WeightBody WeightBody Weight ChangesCentral obesityCoronary Artery Risk Development in Young Adults StudyCoronary arteryDataData CollectionData SetDeteriorationDevelopmentDiabetes MellitusDiabetes preventionDyslipidemiasElderlyEnrollmentFundingFutureGestational AgeGlucose IntoleranceGlycosylated hemoglobin AGoalsHealthHeart DiseasesHigh Risk WomanHourIndividualInfluentialsInstitute of Medicine (U.S.)Insulin ResistanceInterventionLife StyleLinkLipidsMeasurementMeasuresMedical RecordsMetabolicMonitorMorbidity - disease rateNational Heart, Lung, and Blood InstituteNon-Insulin-Dependent Diabetes MellitusOGTTObesityOutcomeOverweightPerinatalPreconception CarePrediabetes syndromePregnancyPregnancy OutcomePremature BirthPreventionPrevention strategyRandomizedRecording of previous eventsReportingResearchRiskRisk FactorsSite-Directed MutagenesisStratificationTestingTimeTranslatingWeightWeight GainWomanWomen&aposs Healthcardiometabolic riskchild bearingcohortdiabetes riskdisorder riskfasting glucosegestational weight gainglucose tolerancehigh riskinsightmenmiddle agemortalityobesity preventionobesity riskoffspringoral glucose toleranceperinatal outcomespreventprospectivepublic health relevancereproductiveyoung adult
项目摘要
   
DESCRIPTION (provided by applicant): Over 50% of U.S. women enter pregnancy overweight or obese, and almost 50% gain more weight during pregnancy than is recommended. Maternal excess adiposity not only leads to greater perinatal morbidity and mortality, but higher weight retention and greater disease risk. Randomized interventions to modify gestational weight gain (GWG), especially among overweight or obese women, have been largely ineffective. Excess maternal adiposity before, during and after pregnancy may result in worse cardiometabolic health for women during the childbearing years. These periods are referred to as "pregnancy-related risk factor changes" that involve increased adiposity, as well as alterations in metabolic risk factors during the preconception, gestational, and post-pregnancy periods. We hypothesize that maternal cardiometabolic risk factor changes (i.e., "trajectories") before pregnancy may increase the risk of excessive GWG and adverse perinatal outcomes (APOs), and that maternal BMI and subsequent weight changes throughout the childbearing years may adversely affect maternal cardiometabolic risk factor development post-pregnancy, and thereby accelerate the progression to glucose intolerance in women during midlife. We propose an ancillary study to the NHLBI funded CARDIA Study, a multi-center longitudinal cohort of 5,115 black and white women and men (18-30 y) enrolled in 1985-1986, and re-examined up to 8 times as of 2011 with retention of 72% of the surviving cohort. Exams included metabolic risk factor (body weight, waist girth, fasting glucose and lipids) measurements every 2-5 years (both before and after pregnancies) in 1986-2011, including oral glucose tolerance testing via 2-hr 75 g OGTTs up to four times from 1996-2011. Women also reported GWG and perinatal outcomes (birth weight, gestational age, GDM, preterm birth) which were validated via medical record abstractions. The proposed study will coincide with the Year 30 CARDIA exam (June 2015-2016) to collect new data on reproductive and offspring health histories, administer a fifth 2-hr 75 g OGTT and measure HbA1c. This study leverages the unique CARDIA datasets that include prospective risk factor measurements from before to after pregnancies, existing GWG and APO data, and additional new data collection to assess progression to glucose tolerance in women. The specific aims are: 1) To evaluate the impact of pre-pregnancy cardiometabolic risk factor trajectories on pregnancy outcomes; 2) To characterize the contributions of weight changes from before, during and after pregnancy to the development of cardiometabolic risk factors for glucose intolerance and 3) To evaluate the independent associations of maternal pre-pregnancy BMI, GWG, and post-pregnancy weight changes on the progression to glucose intolerance. These findings can be translated into individual risk stratification to optimize prevention efforts by identifying women at high- risk fo perinatal morbidity, and subsequent progression to glucose intolerance during the reproductive years.
   
描述(由申请人提供):超过50%的美国妇女进入怀孕超重或肥胖,几乎50%的人在怀孕期间体重增加超过推荐。母亲过度肥胖不仅导致围产期发病率和死亡率增加,而且体重保持率增加,疾病风险增加。改变妊娠期体重增加(GWG)的随机干预措施,特别是在超重或肥胖妇女中,基本上是无效的。在怀孕前、怀孕期间和怀孕后,母亲过度肥胖可能会导致育龄期妇女的心脏代谢健康状况恶化。这些时期被称为“妊娠相关的风险因素变化”,涉及肥胖增加,以及在孕前,妊娠期和妊娠后期间代谢风险因素的改变。我们假设母体心脏代谢危险因素的变化(即,在妊娠前,孕妇的BMI和随后的体重变化(“轨迹”)可能会增加过度GWG和不良围产期结局(APO)的风险,并且在整个生育年龄期间,孕妇的BMI和随后的体重变化可能会对孕妇妊娠后的心脏代谢风险因素的发展产生不利影响,从而加速中年妇女向葡萄糖耐受不良的进展。我们建议对NHLBI资助的CARDIA研究进行一项辅助研究,该研究是一项多中心纵向队列研究,纳入了1985-1986年入组的5,115名黑人和白色女性和男性(18-30岁),截至2011年重新检查了8次,保留了72%的存活队列。检查包括1986-2011年每2-5年(怀孕前后)测量一次代谢风险因素(体重、腰围、空腹血糖和血脂),包括1996-2011年通过2小时75 g OGTT进行的口服葡萄糖耐量试验,最多4次。女性还报告了GWG和围产期结局(出生体重、胎龄、GDM、早产),这些结果通过病历摘要进行了验证。拟议的研究将与30年的心脏检查(2015-2016年6月)相吻合,以收集有关生殖和后代健康史的新数据,进行第五次2小时75 g OGTT并测量HbA 1c。这项研究利用独特的CARDIA数据集,包括从怀孕前到怀孕后的前瞻性风险因素测量,现有的GWG和APO数据,以及额外的新数据收集,以评估女性葡萄糖耐量的进展。具体目标是:1)评价孕前心脏代谢危险因素轨迹对妊娠结局的影响; 2)描述妊娠前、妊娠期间和妊娠后体重变化对葡萄糖耐受不良心脏代谢危险因素发展的贡献; 3)评价母体孕前BMI、GWG和妊娠后体重变化对葡萄糖耐受不良进展的独立相关性。这些发现可以转化为个体风险分层,以通过识别围产期发病率高风险的妇女以及随后在生育期进展为葡萄糖耐受不良的妇女来优化预防工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
                item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ patent.updateTime }}
Erica Pauline Gunderson其他文献
Erica Pauline Gunderson的其他文献
{{
              item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
{{ truncateString('Erica Pauline Gunderson', 18)}}的其他基金
Biomarker of Pancreatic B-cell Loss Predicting Progression to Type 2 Diabetes After Gestational Diabetes
胰腺 B 细胞损失的生物标志物可预测妊娠期糖尿病后进展为 2 型糖尿病
- 批准号:10583645 
- 财政年份:2023
- 资助金额:$ 68.04万 
- 项目类别:
Fetal and Early Postnatal Influences on Child Metabolic Health After Gestational Diabetes
妊娠糖尿病后胎儿和产后早期对儿童代谢健康的影响
- 批准号:10159898 
- 财政年份:2020
- 资助金额:$ 68.04万 
- 项目类别:
Fetal and Early Postnatal Influences on Child Metabolic Health After Gestational Diabetes
妊娠糖尿病后胎儿和产后早期对儿童代谢健康的影响
- 批准号:10399625 
- 财政年份:2020
- 资助金额:$ 68.04万 
- 项目类别:
Fetal and Early Postnatal Influences on Child Metabolic Health After Gestational Diabetes
妊娠糖尿病后胎儿和产后早期对儿童代谢健康的影响
- 批准号:10616503 
- 财政年份:2020
- 资助金额:$ 68.04万 
- 项目类别:
Metabolite Profiles Preceding Progression to Diabetes Mellitus after Gestational Diabetes
妊娠糖尿病后进展为糖尿病之前的代谢特征
- 批准号:10398839 
- 财政年份:2018
- 资助金额:$ 68.04万 
- 项目类别:
Prenatal Blood Pressure Patterns to Predict Pregnancy-Related Hypertension and Later Life Cardiovascular Risk
产前血压模式可预测妊娠相关高血压和晚年心血管风险
- 批准号:10263402 
- 财政年份:2018
- 资助金额:$ 68.04万 
- 项目类别:
Prenatal Blood Pressure Patterns to Predict Pregnancy-Related Hypertension and Later Life Cardiovascular Risk
产前血压模式可预测妊娠相关高血压和晚年心血管风险
- 批准号:10065013 
- 财政年份:2018
- 资助金额:$ 68.04万 
- 项目类别:
Prenatal Blood Pressure Patterns to Predict Pregnancy-Related Hypertension and Later Life Cardiovascular Risk
产前血压模式可预测妊娠相关高血压和晚年心血管风险
- 批准号:10318984 
- 财政年份:2018
- 资助金额:$ 68.04万 
- 项目类别:
Metabolite Profiles Preceding Progression to Diabetes Mellitus after Gestational Diabetes
妊娠糖尿病后进展为糖尿病之前的代谢特征
- 批准号:9920010 
- 财政年份:2018
- 资助金额:$ 68.04万 
- 项目类别:
Infant Temperament and Early Infant Growth and Child Overweight in GDM Offspring
GDM子代的婴儿气质与早期婴儿生长和儿童超重
- 批准号:8766265 
- 财政年份:2014
- 资助金额:$ 68.04万 
- 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:2341426 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Continuing Grant 
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:2341424 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Continuing Grant 
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:10108433 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:EU-Funded 
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:MR/X032809/1 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Fellowship 
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:MR/X034690/1 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Fellowship 
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:24K13490 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:EP/Z00022X/1 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Research Grant 
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:MR/Y003365/1 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Research Grant 
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:2335955 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Standard Grant 
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:AH/Y007549/1 
- 财政年份:2024
- 资助金额:$ 68.04万 
- 项目类别:Research Grant 

 刷新
              刷新
            
















 {{item.name}}会员
              {{item.name}}会员
            



